1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Cell Therapy 1.2.3 Tissue Engineering 1.2.4 Biomaterial 1.2.5 Other 1.3 Market by Application 1.3.1 Global Regenerative Medicine Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Dermatology 1.3.3 Cardiovascular 1.3.4 CNS 1.3.5 Orthopedic 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Regenerative Medicine Market Perspective (2016-2027) 2.2 Regenerative Medicine Growth Trends by Regions 2.2.1 Regenerative Medicine Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Regenerative Medicine Historic Market Share by Regions (2016-2021) 2.2.3 Regenerative Medicine Forecasted Market Size by Regions (2022-2027) 2.3 Regenerative Medicine Industry Dynamic 2.3.1 Regenerative Medicine Market Trends 2.3.2 Regenerative Medicine Market Drivers 2.3.3 Regenerative Medicine Market Challenges 2.3.4 Regenerative Medicine Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Regenerative Medicine Players by Revenue 3.1.1 Global Top Regenerative Medicine Players by Revenue (2016-2021) 3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2016-2021) 3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Regenerative Medicine Revenue 3.4 Global Regenerative Medicine Market Concentration Ratio 3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2020 3.5 Regenerative Medicine Key Players Head office and Area Served 3.6 Key Players Regenerative Medicine Product Solution and Service 3.7 Date of Enter into Regenerative Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Regenerative Medicine Breakdown Data by Type 4.1 Global Regenerative Medicine Historic Market Size by Type (2016-2021) 4.2 Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) 5 Regenerative Medicine Breakdown Data by Application 5.1 Global Regenerative Medicine Historic Market Size by Application (2016-2021) 5.2 Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Regenerative Medicine Market Size (2016-2027) 6.2 North America Regenerative Medicine Market Size by Type 6.2.1 North America Regenerative Medicine Market Size by Type (2016-2021) 6.2.2 North America Regenerative Medicine Market Size by Type (2022-2027) 6.2.3 North America Regenerative Medicine Market Size by Type (2016-2027) 6.3 North America Regenerative Medicine Market Size by Application 6.3.1 North America Regenerative Medicine Market Size by Application (2016-2021) 6.3.2 North America Regenerative Medicine Market Size by Application (2022-2027) 6.3.3 North America Regenerative Medicine Market Size by Application (2016-2027) 6.4 North America Regenerative Medicine Market Size by Country 6.4.1 North America Regenerative Medicine Market Size by Country (2016-2021) 6.4.2 North America Regenerative Medicine Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Regenerative Medicine Market Size (2016-2027) 7.2 Europe Regenerative Medicine Market Size by Type 7.2.1 Europe Regenerative Medicine Market Size by Type (2016-2021) 7.2.2 Europe Regenerative Medicine Market Size by Type (2022-2027) 7.2.3 Europe Regenerative Medicine Market Size by Type (2016-2027) 7.3 Europe Regenerative Medicine Market Size by Application 7.3.1 Europe Regenerative Medicine Market Size by Application (2016-2021) 7.3.2 Europe Regenerative Medicine Market Size by Application (2022-2027) 7.3.3 Europe Regenerative Medicine Market Size by Application (2016-2027) 7.4 Europe Regenerative Medicine Market Size by Country 7.4.1 Europe Regenerative Medicine Market Size by Country (2016-2021) 7.4.2 Europe Regenerative Medicine Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Regenerative Medicine Market Size (2016-2027) 8.2 Asia-Pacific Regenerative Medicine Market Size by Type 8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Regenerative Medicine Market Size by Type (2016-2027) 8.3 Asia-Pacific Regenerative Medicine Market Size by Application 8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Regenerative Medicine Market Size by Application (2016-2027) 8.4 Asia-Pacific Regenerative Medicine Market Size by Region 8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Regenerative Medicine Market Size (2016-2027) 9.2 Latin America Regenerative Medicine Market Size by Type 9.2.1 Latin America Regenerative Medicine Market Size by Type (2016-2021) 9.2.2 Latin America Regenerative Medicine Market Size by Type (2022-2027) 9.2.3 Latin America Regenerative Medicine Market Size by Type (2016-2027) 9.3 Latin America Regenerative Medicine Market Size by Application 9.3.1 Latin America Regenerative Medicine Market Size by Application (2016-2021) 9.3.2 Latin America Regenerative Medicine Market Size by Application (2022-2027) 9.3.3 Latin America Regenerative Medicine Market Size by Application (2016-2027) 9.4 Latin America Regenerative Medicine Market Size by Country 9.4.1 Latin America Regenerative Medicine Market Size by Country (2016-2021) 9.4.2 Latin America Regenerative Medicine Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Regenerative Medicine Market Size (2016-2027) 10.2 Middle East & Africa Regenerative Medicine Market Size by Type 10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Regenerative Medicine Market Size by Type (2016-2027) 10.3 Middle East & Africa Regenerative Medicine Market Size by Application 10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Regenerative Medicine Market Size by Application (2016-2027) 10.4 Middle East & Africa Regenerative Medicine Market Size by Country 10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 DePuy Synthes 11.1.1 DePuy Synthes Company Details 11.1.2 DePuy Synthes Business Overview 11.1.3 DePuy Synthes Regenerative Medicine Introduction 11.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021) 11.1.5 DePuy Synthes Recent Development 11.2 Medtronic 11.2.1 Medtronic Company Details 11.2.2 Medtronic Business Overview 11.2.3 Medtronic Regenerative Medicine Introduction 11.2.4 Medtronic Revenue in Regenerative Medicine Business (2016-2021) 11.2.5 Medtronic Recent Development 11.3 ZimmerBiomet 11.3.1 ZimmerBiomet Company Details 11.3.2 ZimmerBiomet Business Overview 11.3.3 ZimmerBiomet Regenerative Medicine Introduction 11.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021) 11.3.5 ZimmerBiomet Recent Development 11.4 Stryker 11.4.1 Stryker Company Details 11.4.2 Stryker Business Overview 11.4.3 Stryker Regenerative Medicine Introduction 11.4.4 Stryker Revenue in Regenerative Medicine Business (2016-2021) 11.4.5 Stryker Recent Development 11.5 Acelity 11.5.1 Acelity Company Details 11.5.2 Acelity Business Overview 11.5.3 Acelity Regenerative Medicine Introduction 11.5.4 Acelity Revenue in Regenerative Medicine Business (2016-2021) 11.5.5 Acelity Recent Development 11.6 MiMedx Group 11.6.1 MiMedx Group Company Details 11.6.2 MiMedx Group Business Overview 11.6.3 MiMedx Group Regenerative Medicine Introduction 11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) 11.6.5 MiMedx Group Recent Development 11.7 Organogenesis 11.7.1 Organogenesis Company Details 11.7.2 Organogenesis Business Overview 11.7.3 Organogenesis Regenerative Medicine Introduction 11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2016-2021) 11.7.5 Organogenesis Recent Development 11.8 UniQure 11.8.1 UniQure Company Details 11.8.2 UniQure Business Overview 11.8.3 UniQure Regenerative Medicine Introduction 11.8.4 UniQure Revenue in Regenerative Medicine Business (2016-2021) 11.8.5 UniQure Recent Development 11.9 Cellular Dynamics International 11.9.1 Cellular Dynamics International Company Details 11.9.2 Cellular Dynamics International Business Overview 11.9.3 Cellular Dynamics International Regenerative Medicine Introduction 11.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021) 11.9.5 Cellular Dynamics International Recent Development 11.10 Osiris Therapeutics 11.10.1 Osiris Therapeutics Company Details 11.10.2 Osiris Therapeutics Business Overview 11.10.3 Osiris Therapeutics Regenerative Medicine Introduction 11.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) 11.10.5 Osiris Therapeutics Recent Development 11.11 Vcanbio 11.11.1 Vcanbio Company Details 11.11.2 Vcanbio Business Overview 11.11.3 Vcanbio Regenerative Medicine Introduction 11.11.4 Vcanbio Revenue in Regenerative Medicine Business (2016-2021) 11.11.5 Vcanbio Recent Development 11.12 Gamida Cell 11.12.1 Gamida Cell Company Details 11.12.2 Gamida Cell Business Overview 11.12.3 Gamida Cell Regenerative Medicine Introduction 11.12.4 Gamida Cell Revenue in Regenerative Medicine Business (2016-2021) 11.12.5 Gamida Cell Recent Development 11.13 Golden Meditech 11.13.1 Golden Meditech Company Details 11.13.2 Golden Meditech Business Overview 11.13.3 Golden Meditech Regenerative Medicine Introduction 11.13.4 Golden Meditech Revenue in Regenerative Medicine Business (2016-2021) 11.13.5 Golden Meditech Recent Development 11.14 Cytori 11.14.1 Cytori Company Details 11.14.2 Cytori Business Overview 11.14.3 Cytori Regenerative Medicine Introduction 11.14.4 Cytori Revenue in Regenerative Medicine Business (2016-2021) 11.14.5 Cytori Recent Development 11.15 Celgene 11.15.1 Celgene Company Details 11.15.2 Celgene Business Overview 11.15.3 Celgene Regenerative Medicine Introduction 11.15.4 Celgene Revenue in Regenerative Medicine Business (2016-2021) 11.15.5 Celgene Recent Development 11.16 Vericel Corporation 11.16.1 Vericel Corporation Company Details 11.16.2 Vericel Corporation Business Overview 11.16.3 Vericel Corporation Regenerative Medicine Introduction 11.16.4 Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) 11.16.5 Vericel Corporation Recent Development 11.17 Guanhao Biotech 11.17.1 Guanhao Biotech Company Details 11.17.2 Guanhao Biotech Business Overview 11.17.3 Guanhao Biotech Regenerative Medicine Introduction 11.17.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) 11.17.5 Guanhao Biotech Recent Development 11.18 Mesoblast 11.18.1 Mesoblast Company Details 11.18.2 Mesoblast Business Overview 11.18.3 Mesoblast Regenerative Medicine Introduction 11.18.4 Mesoblast Revenue in Regenerative Medicine Business (2016-2021) 11.18.5 Mesoblast Recent Development 11.18 Stemcell Technologies .1 Stemcell Technologies Company Details .2 Stemcell Technologies Business Overview .3 Stemcell Technologies Regenerative Medicine Introduction .4 Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021) .5 Stemcell Technologies Recent Development 11.20 Bellicum Pharmaceuticals 11.20.1 Bellicum Pharmaceuticals Company Details 11.20.2 Bellicum Pharmaceuticals Business Overview 11.20.3 Bellicum Pharmaceuticals Regenerative Medicine Introduction 11.20.4 Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021) 11.20.5 Bellicum Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Cell Therapy Table 3. Key Players of Tissue Engineering Table 4. Key Players of Biomaterial Table 5. Key Players of Other Table 6. Global Regenerative Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Regenerative Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Regenerative Medicine Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Regenerative Medicine Market Share by Regions (2016-2021) Table 10. Global Regenerative Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Regenerative Medicine Market Share by Regions (2022-2027) Table 12. Regenerative Medicine Market Trends Table 13. Regenerative Medicine Market Drivers Table 14. Regenerative Medicine Market Challenges Table 15. Regenerative Medicine Market Restraints Table 16. Global Regenerative Medicine Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Regenerative Medicine Market Share by Players (2016-2021) Table 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020) Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Regenerative Medicine Product Solution and Service Table 23. Date of Enter into Regenerative Medicine Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 26. Global Regenerative Medicine Revenue Market Share by Type (2016-2021) Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Regenerative Medicine Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Regenerative Medicine Revenue Market Share by Application (2016-2021) Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Regenerative Medicine Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 34. North America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million) Table 36. North America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Regenerative Medicine Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Regenerative Medicine Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Regenerative Medicine Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Regenerative Medicine Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Regenerative Medicine Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Regenerative Medicine Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Regenerative Medicine Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Regenerative Medicine Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Regenerative Medicine Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Regenerative Medicine Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Regenerative Medicine Market Size by Country (2022-2027) & (US$ Million) Table 63. DePuy Synthes Company Details Table 64. DePuy Synthes Business Overview Table 65. DePuy Synthes Regenerative Medicine Product Table 66. DePuy Synthes Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 67. DePuy Synthes Recent Development Table 68. Medtronic Company Details Table 69. Medtronic Business Overview Table 70. Medtronic Regenerative Medicine Product Table 71. Medtronic Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 72. Medtronic Recent Development Table 73. ZimmerBiomet Company Details Table 74. ZimmerBiomet Business Overview Table 75. ZimmerBiomet Regenerative Medicine Product Table 76. ZimmerBiomet Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 77. ZimmerBiomet Recent Development Table 78. Stryker Company Details Table 79. Stryker Business Overview Table 80. Stryker Regenerative Medicine Product Table 81. Stryker Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 82. Stryker Recent Development Table 83. Acelity Company Details Table 84. Acelity Business Overview Table 85. Acelity Regenerative Medicine Product Table 86. Acelity Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 87. Acelity Recent Development Table 88. MiMedx Group Company Details Table 89. MiMedx Group Business Overview Table 90. MiMedx Group Regenerative Medicine Product Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 92. MiMedx Group Recent Development Table 93. Organogenesis Company Details Table 94. Organogenesis Business Overview Table 95. Organogenesis Regenerative Medicine Product Table 96. Organogenesis Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 97. Organogenesis Recent Development Table 98. UniQure Company Details Table 99. UniQure Business Overview Table 100. UniQure Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 101. UniQure Recent Development Table 102. Cellular Dynamics International Company Details Table 103. Cellular Dynamics International Business Overview Table 104. Cellular Dynamics International Regenerative Medicine Product Table 105. Cellular Dynamics International Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 106. Cellular Dynamics International Recent Development Table 107. Osiris Therapeutics Company Details Table 108. Osiris Therapeutics Business Overview Table 109. Osiris Therapeutics Regenerative Medicine Product Table 110. Osiris Therapeutics Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 111. Osiris Therapeutics Recent Development Table 112. Vcanbio Company Details Table 113. Vcanbio Business Overview Table 114. Vcanbio Regenerative Medicine Product Table 115. Vcanbio Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 116. Vcanbio Recent Development Table 117. Gamida Cell Company Details Table 118. Gamida Cell Business Overview Table 119. Gamida Cell Regenerative Medicine Product Table 120. Gamida Cell Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 121. Gamida Cell Recent Development Table 122. Golden Meditech Company Details Table 123. Golden Meditech Business Overview Table 124. Golden Meditech Regenerative Medicine Product Table 125. Golden Meditech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 126. Golden Meditech Recent Development Table 127. Cytori Company Details Table 128. Cytori Business Overview Table 129. Cytori Regenerative Medicine Product Table 130. Cytori Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 131. Cytori Recent Development Table 132. Celgene Company Details Table 133. Celgene Business Overview Table 134. Celgene Regenerative Medicine Product Table 135. Celgene Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 136. Celgene Recent Development Table 137. Vericel Corporation Company Details Table 138. Vericel Corporation Business Overview Table 139. Vericel Corporation Regenerative Medicine Product Table 140. Vericel Corporation Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 141. Vericel Corporation Recent Development Table 142. Guanhao Biotech Company Details Table 143. Guanhao Biotech Business Overview Table 144. Guanhao Biotech Regenerative Medicine Product Table 145. Guanhao Biotech Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 146. Guanhao Biotech Recent Development Table 147. Mesoblast Company Details Table 148. Mesoblast Business Overview Table 149. Mesoblast Regenerative Medicine Product Table 150. Mesoblast Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 151. Mesoblast Recent Development Table 152. Stemcell Technologies Company Details Table 153. Stemcell Technologies Business Overview Table 154. Stemcell Technologies Regenerative Medicine Product Table 155. Stemcell Technologies Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 156. Stemcell Technologies Recent Development Table 157. Bellicum Pharmaceuticals Company Details Table 158. Bellicum Pharmaceuticals Business Overview Table 159. Bellicum Pharmaceuticals Regenerative Medicine Product Table 160. Bellicum Pharmaceuticals Revenue in Regenerative Medicine Business (2016-2021) & (US$ Million) Table 161. Bellicum Pharmaceuticals Recent Development Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Regenerative Medicine Market Share by Type: 2020 VS 2027 Figure 2. Cell Therapy Features Figure 3. Tissue Engineering Features Figure 4. Biomaterial Features Figure 5. Other Features Figure 6. Global Regenerative Medicine Market Share by Application: 2020 VS 2027 Figure 7. Dermatology Case Studies Figure 8. Cardiovascular Case Studies Figure 9. CNS Case Studies Figure 10. Orthopedic Case Studies Figure 11. Others Case Studies Figure 12. Regenerative Medicine Report Years Considered Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Regenerative Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Regenerative Medicine Market Share by Regions: 2020 VS 2027 Figure 16. Global Regenerative Medicine Market Share by Regions (2022-2027) Figure 17. Global Regenerative Medicine Market Share by Players in 2020 Figure 18. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Medicine as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2020 Figure 20. Global Regenerative Medicine Revenue Market Share by Type (2016-2021) Figure 21. Global Regenerative Medicine Revenue Market Share by Type (2022-2027) Figure 22. North America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Regenerative Medicine Market Share by Type (2016-2027) Figure 24. North America Regenerative Medicine Market Share by Application (2016-2027) Figure 25. North America Regenerative Medicine Market Share by Country (2016-2027) Figure 26. United States Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Regenerative Medicine Market Share by Type (2016-2027) Figure 30. Europe Regenerative Medicine Market Share by Application (2016-2027) Figure 31. Europe Regenerative Medicine Market Share by Country (2016-2027) Figure 32. Germany Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Regenerative Medicine Market Share by Type (2016-2027) Figure 40. Asia-Pacific Regenerative Medicine Market Share by Application (2016-2027) Figure 41. Asia-Pacific Regenerative Medicine Market Share by Region (2016-2027) Figure 42. China Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Regenerative Medicine Market Share by Type (2016-2027) Figure 50. Latin America Regenerative Medicine Market Share by Application (2016-2027) Figure 51. Latin America Regenerative Medicine Market Share by Country (2016-2027) Figure 52. Mexico Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Regenerative Medicine Market Share by Type (2016-2027) Figure 56. Middle East & Africa Regenerative Medicine Market Share by Application (2016-2027) Figure 57. Middle East & Africa Regenerative Medicine Market Share by Country (2016-2027) Figure 58. Turkey Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Regenerative Medicine Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. DePuy Synthes Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 62. Medtronic Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 63. ZimmerBiomet Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 64. Stryker Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 65. Acelity Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 66. MiMedx Group Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 67. Organogenesis Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 68. UniQure Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 69. Cellular Dynamics International Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 70. Osiris Therapeutics Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 71. Vcanbio Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 72. Gamida Cell Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 73. Golden Meditech Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 74. Cytori Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 75. Celgene Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 76. Vericel Corporation Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 77. Guanhao Biotech Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 78. Mesoblast Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 79. Stemcell Technologies Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 80. Bellicum Pharmaceuticals Revenue Growth Rate in Regenerative Medicine Business (2016-2021) Figure 81. Bottom-up and Top-down Approaches for This Report Figure 82. Data Triangulation Figure 83. Key Executives Interviewed